Royalty Pharma Dividends and Buybacks
Dividend criteria checks 2/6
Royalty Pharma is a dividend paying company with a current yield of 3.2% that is well covered by earnings. Next payment date is on 10th December, 2024 with an ex-dividend date of 15th November, 2024.
Key information
3.2%
Dividend yield
1.4%
Buyback Yield
| Total Shareholder Yield | 4.6% |
| Future Dividend Yield | 3.5% |
| Dividend Growth | 20.2% |
| Next dividend pay date | 10 Dec 24 |
| Ex dividend date | 15 Nov 24 |
| Dividend per share | US$0.840 |
| Payout ratio | 32% |
Recent dividend and buyback updates
Royalty Pharma (NASDAQ:RPRX) Has Affirmed Its Dividend Of $0.21
Oct 14
Royalty Pharma (NASDAQ:RPRX) Has Announced A Dividend Of $0.21
Jul 22Recent updates
Solid Earnings May Not Tell The Whole Story For Royalty Pharma (NASDAQ:RPRX)
Nov 13Royalty Pharma: Massive Opportunity Ahead
Nov 09Royalty Pharma (NASDAQ:RPRX) Has Affirmed Its Dividend Of $0.21
Oct 14Earnings Tell The Story For Royalty Pharma plc (NASDAQ:RPRX)
Oct 09Royalty Pharma (NASDAQ:RPRX) Takes On Some Risk With Its Use Of Debt
Aug 28Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating
Aug 22Royalty Pharma: Busy Putting Capital To Work
Aug 11Royalty Pharma (NASDAQ:RPRX) Has Announced A Dividend Of $0.21
Jul 22Royalty Pharma plc (NASDAQ:RPRX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Royalty Pharma: Solid Start Of The Year, Buy Confirmed
May 11Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
Apr 28Unpleasant Surprises Could Be In Store For Royalty Pharma plc's (NASDAQ:RPRX) Shares
Apr 25Is Royalty Pharma (NASDAQ:RPRX) Using Too Much Debt?
Apr 04Royalty Pharma's (NASDAQ:RPRX) Earnings Are Weaker Than They Seem
Feb 22Royalty Pharma: Solid Operational Performance
Feb 19Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At $0.21
Jan 31Royalty Pharma: One Of The Best Names In Pharmaceuticals
Jan 22Royalty Pharma plc's (NASDAQ:RPRX) Share Price Matching Investor Opinion
Dec 26Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's
May 12Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.20
Apr 20Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20
Jan 16Royalty Pharma to co-fund development of schizophrenia drug with Merck
Oct 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, RPRX has been paying a dividend for less than 10 years.
Growing Dividend: RPRX's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Royalty Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RPRX) | 3.2% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (RPRX) (up to 3 years) | 3.5% |
Notable Dividend: RPRX's dividend (3.2%) is higher than the bottom 25% of dividend payers in the US market (1.4%).
High Dividend: RPRX's dividend (3.2%) is low compared to the top 25% of dividend payers in the US market (4.32%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32.5%), RPRX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: RPRX is paying a dividend but the company has no free cash flows.